NCM
CELG

Narwhal Capital Management’s Celgene Corp CELG Stock Holding History

Narwhal Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,472
Closed -$233K – 144
2019
Q1 		$233K Buy
+2,472
New +$216K 0.05% 135
2017
Q4 		– Sell
-8,840
Closed -$1.29M – 157
2017
Q3 		$1.29M Sell
8,840
-50
-0.6% -$6.81K 0.32% 90
2017
Q2 		$1.16M Buy
8,890
+2,550
+40% +$312K 0.3% 87
2017
Q1 		$789K Buy
6,340
+525
+9% +$62.8K 0.22% 100
2016
Q4 		$673K Buy
5,815
+3,895
+203% +$434K 0.2% 99
2016
Q3 		$201K Buy
+1,920
New +$208K 0.06% 134

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Narwhal Capital Management's CELG Position: Q2 2019 in Review

Narwhal Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,472 shares — an estimated $233K sold.

Narwhal Capital Management first reported a position in CELG in Q3 2016 and held it in 6 quarters. The position peaked at $1.29M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Narwhal Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Narwhal Capital Management sold 2,472 Celgene Corp shares in Q2 2019, an estimated $233K.
  • Narwhal Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 6 quarters.
  • Narwhal Capital Management's Celgene Corp position peaked at $1.29M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Narwhal Capital Management's 13F filing for Q2 2019, filed 30 Jul 2019.